Pancreatic Cancer Research

ResearcherUniversity of ManchesterActive in the last 2 years

Nicola de Liguori Carino

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6780-372X; OpenAlex author ID A5083474436. Sources: OpenAlex.

Their work

Papers
11 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
48
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: 2 papers · 2022: 3 papers · 2023: none · 2024: none · 2025: 3 papers · 2026: 1 paper

Papers 11

  1. Survival After Irreversible Electroporation in Unresectable Locally Advanced Pancreatic Cancer: A Meta-Analysis. Last author DOI 10.1016/j.jss.2026.08.030↗
  2. Impact of social deprivation upon the preoperative pathway and early surgical outcomes after pancreatoduodenectomy for PDAC and non-PDAC periampullary cancer i… Co-author DOI 10.1016/j.hpb.2025.07.007↗
  3. The role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography-derived parameters as prognostic factors in patients undergoing resection f… Co-author DOI 10.1016/j.surg.2025.109271↗
  4. Irreversible electroporation as an intraoperative adjunctive treatment for locally advanced pancreatic cancer after neoadjuvant therapy: An initial clinical ex… Last author DOI 10.14701/ahbps.24-193↗
  5. Clinical challenges associated with utility of neoadjuvant treatment in patients with pancreatic ductal adenocarcinoma. First author DOI 10.1016/j.ejso.2022.02.014↗
  6. A fast-track surgery programme leads to timelier treatment and higher resection rates in pancreatic cancer. Co-author DOI 10.1016/j.hpb.2021.10.019↗
  7. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-… Co-author DOI 10.1136/bmjopen-2021-050166↗
  8. Understanding pancreatic exocrine insufficiency and replacement therapy in pancreatic cancer. First author DOI 10.1016/j.ejso.2020.03.006↗
  9. Impact of SARS-CoV-2 pandemic on pancreatic cancer services and treatment pathways: United Kingdom experience. Co-author DOI 10.1016/j.hpb.2021.03.003↗
  10. The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000001486↗
  11. Irreversible Electroporation in pancreatic ductal adenocarcinoma: Is there a role in conjunction with conventional treatment? Co-author DOI 10.1016/j.ejso.2018.07.047↗

Closest collaborators

The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ajith Kumar Siriwardena · 6 shared papers, 2018–2026 · strength 1.14
  2. Saurabh Jamdar · 4 shared papers, 2020–2026 · strength 0.72
  3. Thomas Satyadas · 4 shared papers, 2020–2026 · strength 0.72
  4. Agastya Patel · 2 shared papers, 2025 · strength 0.54
  5. Francesco Lancellotti · 2 shared papers, 2025 · strength 0.54
  6. Juan W. Valle · 3 shared papers, 2018–2022 · strength 0.37
  7. Mairead Geraldine McNamara · 3 shared papers, 2018–2022 · strength 0.37
  8. Derek A O'Reilly · 3 shared papers, 2018–2022 · strength 0.34
  9. Keith John Roberts · 2 shared papers, 2021 · strength 0.30
  10. Ángela Lamarca · 2 shared papers, 2020–2022 · strength 0.28
  11. Richard A Hubner · 2 shared papers, 2020–2022 · strength 0.28
  12. Ganesh Radhakrishna · 2 shared papers, 2018–2022 · strength 0.26
  13. Shahin Hajibandeh · 1 shared paper, 2026 · strength 0.25
  14. Shahab Hajibandeh · 1 shared paper, 2026 · strength 0.25
  15. Sarah F. Powell-Brett · 1 shared paper, 2021 · strength 0.22
  16. Jenifer Barrie · 1 shared paper, 2025 · strength 0.21
  17. Simon Gray · 1 shared paper, 2022 · strength 0.17
  18. David Christopher Bartlett · 1 shared paper, 2022 · strength 0.13
  19. Kurinchi Selvan Gurusamy · 1 shared paper, 2022 · strength 0.13
  20. Paula Ghaneh · 1 shared paper, 2022 · strength 0.13
  21. Daniel H. Palmer · 1 shared paper, 2022 · strength 0.13
  22. Zainab L. Rai · 1 shared paper, 2022 · strength 0.13
  23. Brian Ritchie Davidson · 1 shared paper, 2022 · strength 0.13
  24. Derek Manas · 1 shared paper, 2022 · strength 0.13
  25. Abdullah Khalid Malik · 1 shared paper, 2020 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.